<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35514314</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>09</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>15</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1791-244X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>49</Volume>
            <Issue>6</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>International journal of molecular medicine</Title>
          <ISOAbbreviation>Int J Mol Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Starvation mediates pancreatic cancer cell sensitivity to ferroptosis via ERK1/2, JNK and changes in the cell mesenchymal state.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">84</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.3892/ijmm.2022.5140</ELocationID>
        <Abstract>
          <AbstractText>Pancreatic cancer is a highly metastatic and therapy‑resistant disease. In the present study, the prospects of a novel approach to kill pancreatic cancer cells were examined: Starvation combined with ferroptosis induction. Established pancreatic cancer cell lines (Miapaca2, Panc‑1, Su.86.86 and T3M4), as well as a unique cell line, Capan‑26, which was originally derived in the authors' laboratory, were used. Cells were deprived from growth factors, amino acids and pseudo‑starved using treatment with mTOR inhibitors; erastin was used to induce ferroptosis. Cell viability and lipid peroxidation measurements using flow cytometry revealed that the starved pancreatic cancer cells reacted differently to ferroptosis induction: The Panc‑1, Su.86.86 and T3M4 cells gained sensitivity, while the Miapaca2 cells acquired resistance. Fluorescence microscopy revealed that ERK1/2 translocated to the nucleus of the starved pancreatic cancer cells. Moreover, ERK1/2 pharmacological inhibition with SCH772984 prevented erastin‑induced ferroptosis in the starved Panc‑1, Su.86.86 and T3M4 cells. Confocal microscopy also indicated JNK activation. However, the inhibition of this kinase revealed its unexpected role in oxidative stress management: Treatment with the JNK inhibitor, SP600125, increased the viability of pseudo‑starved cells following erastin treatment. In addition, the FBS‑starved Miapaca2 and Capan‑26 cells transitioned between epithelial and mesenchymal cell states. The results were further confirmed using wound healing assays, western blot analysis and microscopic analysis of epithelial‑to‑mesenchymal transition (EMT) markers. Mesenchymal properties were associated with a higher sensitivity to erastin, whereas epithelial‑like cells were more resistant. Finally, it was demonstrated that compounds targeting EMT‑related signaling pathways increased cell sensitivity to erastin. On the whole, these results confirm that in starved pancreatic cancer cells, ERK1/2 and JNK signaling, as well as switching between epithelial and mesenchymal states mediates sensitivity to erastin and reveal novel therapeutic prospects of the combination of starvation with ferroptosis induction.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Zalyte</LastName>
            <ForeName>Egle</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Proteomics Centre, Institute of Biochemistry, Vilnius University Life Sciences Centre, LT‑10257 Vilnius, Lithuania.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cicenas</LastName>
            <ForeName>Jonas</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Proteomics Centre, Institute of Biochemistry, Vilnius University Life Sciences Centre, LT‑10257 Vilnius, Lithuania.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>05</Month>
          <Day>06</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Int J Mol Med</MedlineTA>
        <NlmUniqueID>9810955</NlmUniqueID>
        <ISSNLinking>1107-3756</ISSNLinking>
      </MedlineJournalInfo>
      <SupplMeshList>
        <SupplMeshName Type="Disease" UI="C562463">Pancreatic Carcinoma</SupplMeshName>
      </SupplMeshList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D058750" MajorTopicYN="N">Epithelial-Mesenchymal Transition</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000079403" MajorTopicYN="Y">Ferroptosis</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020935" MajorTopicYN="N">MAP Kinase Signaling System</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010190" MajorTopicYN="Y">Pancreatic Neoplasms</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">ERK1/2</Keyword>
        <Keyword MajorTopicYN="N">JNK</Keyword>
        <Keyword MajorTopicYN="N">ferroptosis</Keyword>
        <Keyword MajorTopicYN="N">pancreatic cancer</Keyword>
        <Keyword MajorTopicYN="N">resistance</Keyword>
        <Keyword MajorTopicYN="N">starvation</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare that they have no competing interests.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>22</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>5</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>6</Day>
          <Hour>5</Hour>
          <Minute>13</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>10</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35514314</ArticleId>
        <ArticleId IdType="pmc">PMC9106375</ArticleId>
        <ArticleId IdType="doi">10.3892/ijmm.2022.5140</ArticleId>
        <ArticleId IdType="pii">84</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–249. doi: 10.3322/caac.21660.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3322/caac.21660</ArticleId>
            <ArticleId IdType="pubmed">33538338</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Spadi R, Brusa F, Ponzetti A, Chiappino I, Birocco N, Ciuffreda L, Satolli MA. Current therapeutic strategies for advanced pancreatic cancer: A review for clinicians. World J Clin Oncol. 2016;7:27–43. doi: 10.5306/wjco.v7.i1.27.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5306/wjco.v7.i1.27</ArticleId>
            <ArticleId IdType="pmc">PMC4734936</ArticleId>
            <ArticleId IdType="pubmed">26862489</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Petrillo A, Pappalardo A, Calabrese F, Tirino G, Pompella L, Ventriglia J, Laterza MM, Caterino M, Sforza V, Iranzo V, et al.  First line nab-paclitaxel plus gemcitabine in elderly metastatic pancreatic patients: A good choice beyond age. J Gastroint Oncol. 2019;10:910–917. doi: 10.21037/jgo.2019.06.02.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.21037/jgo.2019.06.02</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sarabi M, Mais L, Oussaid N, Desseigne F, Guibert P, De La Fouchardiere C. Use of gemcitabine as a second-line treatment following chemotherapy with folfirinox for metastatic pancreatic adenocarcinoma. Oncol Lett. 2017;13:4917–4924. doi: 10.3892/ol.2017.6061.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3892/ol.2017.6061</ArticleId>
            <ArticleId IdType="pmc">PMC5453056</ArticleId>
            <ArticleId IdType="pubmed">28599496</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ferlay J, Partensky C, Bray F. More deaths from pancreatic cancer than breast cancer in the EU by 2017. Acta Oncol. 2016;55:1158–1160. doi: 10.1080/0284186X.2016.1197419.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/0284186X.2016.1197419</ArticleId>
            <ArticleId IdType="pubmed">27551890</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS, et al.  Ferroptosis: An iron-dependent form of nonapoptotic cell death. Cell. 2012;149:1060–1072. doi: 10.1016/j.cell.2012.03.042.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2012.03.042</ArticleId>
            <ArticleId IdType="pmc">PMC3367386</ArticleId>
            <ArticleId IdType="pubmed">22632970</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Han C, Liu Y, Dai R, Ismail N, Su W, Li B. Ferroptosis and its potential role in human diseases. Front Pharmacol. 2020;11:239. doi: 10.3389/fphar.2020.00239.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fphar.2020.00239</ArticleId>
            <ArticleId IdType="pmc">PMC7090218</ArticleId>
            <ArticleId IdType="pubmed">32256352</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Basuli D, Tesfay L, Deng Z, Paul B, Yamamoto Y, Ning G, Xian W, Mckeon F, Lynch M, Crum CP, et al.  Iron addiction: A novel therapeutic target in ovarian cancer. Oncogene. 2017;36:4089–4099. doi: 10.1038/onc.2017.11.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/onc.2017.11</ArticleId>
            <ArticleId IdType="pmc">PMC5540148</ArticleId>
            <ArticleId IdType="pubmed">28319068</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eling N, Reuter L, Hazin J, Hamacher-Brady A, Brady NR. Identification of artesunate as a specific activator of ferroptosis in pancreatic cancer cells. Oncoscience. 2015;2:517–532. doi: 10.18632/oncoscience.160.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.18632/oncoscience.160</ArticleId>
            <ArticleId IdType="pmc">PMC4468338</ArticleId>
            <ArticleId IdType="pubmed">26097885</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li B, Yang L, Peng X, Fan Q, Wei S, Yang S, Li X, Jin H, Wu B, Huang M, et al.  Emerging mechanisms and applications of ferroptosis in the treatment of resistant cancers. Biomed Pharmacother. 2020;130:110710. doi: 10.1016/j.biopha.2020.110710.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.biopha.2020.110710</ArticleId>
            <ArticleId IdType="pubmed">33568263</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gagliardi M, Saverio V, Monzani R, Ferrari E, Piacentini M, Corazzari M. Ferroptosis: A new unexpected chance to treat metastatic melanoma? Cell Cycle. 2020;19:2411–2425. doi: 10.1080/15384101.2020.1806426.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/15384101.2020.1806426</ArticleId>
            <ArticleId IdType="pmc">PMC7553499</ArticleId>
            <ArticleId IdType="pubmed">32816618</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu H, Schreiber SL, Stockwell BR. Targeting dependency on the GPX4 lipid peroxide repair pathway for cancer therapy. Biochemistry. 2018;57:2059–2060. doi: 10.1021/acs.biochem.8b00307.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/acs.biochem.8b00307</ArticleId>
            <ArticleId IdType="pmc">PMC5962875</ArticleId>
            <ArticleId IdType="pubmed">29584411</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Viswanathan VS, Ryan MJ, Dhruv HD, Gill S, Eichhoff OM, Seashore-Ludlow B, Kaffenberger SD, Eaton JK, Shimada K, Aguirre AJ, et al.  Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway. Nature. 2017;547:453–457. doi: 10.1038/nature23007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature23007</ArticleId>
            <ArticleId IdType="pmc">PMC5667900</ArticleId>
            <ArticleId IdType="pubmed">28678785</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Koppula P, Zhuang L, Gan B. Cystine transporter SLC7A11/xCT in cancer: Ferroptosis, nutrient dependency, and cancer therapy. Protein Cell. 2021;12:599–620. doi: 10.1007/s13238-020-00789-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s13238-020-00789-5</ArticleId>
            <ArticleId IdType="pmc">PMC8310547</ArticleId>
            <ArticleId IdType="pubmed">33000412</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Son J, Lyssiotis CA, Ying H, Wang X, Hua S, Ligorio M, Perera RM, Ferrone CR, Mullarky E, Shyh-Chang N, et al.  Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway. Nature. 2013;496:101–105. doi: 10.1038/nature12040.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature12040</ArticleId>
            <ArticleId IdType="pmc">PMC3656466</ArticleId>
            <ArticleId IdType="pubmed">23535601</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu Q, Zhang H, Jiang X, Qian C, Liu Z, Luo D. Factors involved in cancer metastasis: A better understanding to 'seed and soil' hypothesis. Mol Cancer. 2017;16:176. doi: 10.1186/s12943-017-0742-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12943-017-0742-4</ArticleId>
            <ArticleId IdType="pmc">PMC5712107</ArticleId>
            <ArticleId IdType="pubmed">29197379</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ni B, Ghosh B, Paldy FS, Colin R, Heimerl T, Sourjik V. Evolutionary remodeling of bacterial motility checkpoint control. Cell Rep. 2017;18:866–877. doi: 10.1016/j.celrep.2016.12.088.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.celrep.2016.12.088</ArticleId>
            <ArticleId IdType="pmc">PMC5289928</ArticleId>
            <ArticleId IdType="pubmed">28122238</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gancedo JM. Control of pseudohyphae formation in Saccharomyces cerevisiae. FEMS Microbiol Rev. 2001;25:107–123. doi: 10.1111/j.1574-6976.2001.tb00573.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1574-6976.2001.tb00573.x</ArticleId>
            <ArticleId IdType="pubmed">11152942</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Keenan MM, Chi JT. Alternative fuels for cancer cells. Cancer J. 2015;21:49–55. doi: 10.1097/PPO.0000000000000104.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/PPO.0000000000000104</ArticleId>
            <ArticleId IdType="pmc">PMC4380238</ArticleId>
            <ArticleId IdType="pubmed">25815843</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Commisso C, Davidson SM, Soydaner-Azeloglu RG, Parker SJ, Kamphorst JJ, Hackett S, Grabocka E, Nofal M, Drebin JA, Thompson CB, et al.  Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells. Nature. 2013;497:633–637. doi: 10.1038/nature12138.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature12138</ArticleId>
            <ArticleId IdType="pmc">PMC3810415</ArticleId>
            <ArticleId IdType="pubmed">23665962</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Martinez-Outschoorn UE, Lisanti MP, Sotgia F. Catabolic cancer-associated fibroblasts transfer energy and biomass to anabolic cancer cells, fueling tumor growth. Semin Cancer Biol. 2014;25:47–60. doi: 10.1016/j.semcancer.2014.01.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.semcancer.2014.01.005</ArticleId>
            <ArticleId IdType="pubmed">24486645</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang S, Wang X, Contino G, Liesa M, Sahin E, Ying H, Bause A, Li Y, Stommel JM, Dell'antonio G, et al.  Pancreatic cancers require autophagy for tumor growth. Genes Devel. 2011;25:717–729. doi: 10.1101/gad.2016111.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1101/gad.2016111</ArticleId>
            <ArticleId IdType="pmc">PMC3070934</ArticleId>
            <ArticleId IdType="pubmed">21406549</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lugano R, Ramachandran M, Dimberg A. Tumor angiogenesis: Causes, consequences, challenges and opportunities. Cell Mol Life Sci. 2020;77:1745–1770. doi: 10.1007/s00018-019-03351-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00018-019-03351-7</ArticleId>
            <ArticleId IdType="pmc">PMC7190605</ArticleId>
            <ArticleId IdType="pubmed">31690961</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Prabhakar NR, Semenza GL. Adaptive and maladaptive cardiorespiratory responses to continuous and intermittent hypoxia mediated by hypoxia-inducible factors 1-2. Physiol Rev. 2012;92:967–1003. doi: 10.1152/physrev.00030.2011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/physrev.00030.2011</ArticleId>
            <ArticleId IdType="pmc">PMC3893888</ArticleId>
            <ArticleId IdType="pubmed">22811423</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kuczynski EA, Vermeulen PB, Pezzella F, Kerbel RS, Reynolds AR. Vessel co-option in cancer. Nat Rev Clin Oncol. 2019;16:469–493. doi: 10.1038/s41571-019-0181-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41571-019-0181-9</ArticleId>
            <ArticleId IdType="pubmed">30816337</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Neophytou CM, Panagi M, Stylianopoulos T, Papageorgis P. The role of tumor microenvironment in cancer metastasis: Molecular mechanisms and therapeutic opportunities. Cancers (Basel) 2021;13:2053. doi: 10.3390/cancers13092053.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/cancers13092053</ArticleId>
            <ArticleId IdType="pmc">PMC8122975</ArticleId>
            <ArticleId IdType="pubmed">33922795</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Janssen LME, Ramsay EE, Logsdon CD, Overwijk WW. The immune system in cancer metastasis: Friend or foe? J Immunotherapy Cancer. 2017;5:79. doi: 10.1186/s40425-017-0283-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s40425-017-0283-9</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang RA, Lu YY, Fan DM. Reasons for cancer metastasis: A holistic perspective. Mol Clin Oncol. 2015;3:1199–1202. doi: 10.3892/mco.2015.623.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3892/mco.2015.623</ArticleId>
            <ArticleId IdType="pmc">PMC4665943</ArticleId>
            <ArticleId IdType="pubmed">26807220</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Trauzold A, Siegmund D, Schniewind B, Sipos B, Egberts J, Zorenkov D, Emme D, Röder C, Kalthoff H, Wajant H. TRAIL promotes metastasis of human pancreatic ductal adenocarcinoma. Oncogene. 2006;25:7434–7439. doi: 10.1038/sj.onc.1209719.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.onc.1209719</ArticleId>
            <ArticleId IdType="pubmed">16751802</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jiao D, Cai Z, Choksi S, Ma D, Choe M, Kwon HN, Baik JY, Rowan BG, Liu C, Liu ZG. Necroptosis of tumor cells leads to tumor necrosis and promotes tumor metastasis. Cell Res. 2018;28:868–870. doi: 10.1038/s41422-018-0058-y.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41422-018-0058-y</ArticleId>
            <ArticleId IdType="pmc">PMC6082890</ArticleId>
            <ArticleId IdType="pubmed">29941926</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zalyte E, Dedonyte V, Kurlinkus B, Sileikis A, Schemmer P, Valius M. Establishment and characterization of a new pancreatic ductal adenocarcinoma cell line capan-26. Anticancer Res. 2021;41:1401–1406. doi: 10.21873/anticanres.14897.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.21873/anticanres.14897</ArticleId>
            <ArticleId IdType="pubmed">33788731</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ger M, Žalytė E, Kaupinis A, Kurlinkus B, Petrulionis M, Šileikis A, Strupas K, Valius M. Primary pancreatic ductal adenocarcinoma cell cultures represent the features of native tumours. Biologija. 2019;65:20–33. doi: 10.6001/biologija.v65i1.3983.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.6001/biologija.v65i1.3983</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rabanal-Ruiz Y, Otten EG, Korolchuk VI. mTORC1 as the main gateway to autophagy. Essays Biochem. 2017;61:565–584. doi: 10.1042/EBC20170027.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1042/EBC20170027</ArticleId>
            <ArticleId IdType="pmc">PMC5869864</ArticleId>
            <ArticleId IdType="pubmed">29233869</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Soares HP, Ni Y, Kisfalvi K, Sinnett-Smith J, Rozengurt E. Different patterns of Akt and ERK feedback activation in response to rapamycin, active-site mTOR inhibitors and metformin in pancreatic cancer cells. PLoS One. 2013;8:e57289. doi: 10.1371/journal.pone.0057289.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0057289</ArticleId>
            <ArticleId IdType="pmc">PMC3578870</ArticleId>
            <ArticleId IdType="pubmed">23437362</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liou GY, Döppler H, DelGiorno KE, Zhang L, Leitges M, Crawford HC, Murphy MP, Storz P. Mutant kras-induced mitochondrial oxidative stress in acinar cells upregulates EGFR signaling to drive formation of pancreatic precancerous lesions. Cell Rep. 2016;14:2325–2336. doi: 10.1016/j.celrep.2016.02.029.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.celrep.2016.02.029</ArticleId>
            <ArticleId IdType="pmc">PMC4794374</ArticleId>
            <ArticleId IdType="pubmed">26947075</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Palmieri VO, Grattagliano I, Palasciano G. Ethanol induces secretion of oxidized proteins by pancreatic acinar cells. Cell Biol Toxicol. 2007;23:459–464. doi: 10.1007/s10565-007-9007-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10565-007-9007-0</ArticleId>
            <ArticleId IdType="pubmed">17429743</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhu S, Zhang Q, Sun X, Zeh HJ, III, Lotze MT, Kang R, Tang D. HSPA5 regulates ferroptotic cell death in cancer cells. Cancer Res. 2017;77:2064–2077. doi: 10.1158/0008-5472.CAN-16-1979.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/0008-5472.CAN-16-1979</ArticleId>
            <ArticleId IdType="pmc">PMC5392369</ArticleId>
            <ArticleId IdType="pubmed">28130223</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>White EZ, Pennant NM, Carter JR, Hawsawi O, Odero-Marah V, Hinton CV. Serum deprivation initiates adaptation and survival to oxidative stress in prostate cancer cells. Sci Rep. 2020;10:12505. doi: 10.1038/s41598-020-68668-x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41598-020-68668-x</ArticleId>
            <ArticleId IdType="pmc">PMC7385110</ArticleId>
            <ArticleId IdType="pubmed">32719369</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee H, Zandkarimi F, Zhang Y, Meena JK, Kim J, Zhuang L, Tyagi S, Ma L, Westbrook TF, Steinberg GR, et al.  Energy-stress-mediated AMPK activation inhibits ferroptosis. Nat Cell Biol. 2020;22:225–234. doi: 10.1038/s41556-020-0461-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41556-020-0461-8</ArticleId>
            <ArticleId IdType="pmc">PMC7008777</ArticleId>
            <ArticleId IdType="pubmed">32029897</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu CA, Chao Y, Shiah SG, Lin WW. Nutrient deprivation induces the warburg effect through ROS/AMPK-dependent activation of pyruvate dehydrogenase kinase. Biochimica et biophysica Acta. 2013;1833:1147–1156. doi: 10.1016/j.bbamcr.2013.01.025.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbamcr.2013.01.025</ArticleId>
            <ArticleId IdType="pubmed">23376776</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sato H, Nomura S, Maebara K, Sato K, Tamba M, Bannai S. Transcriptional control of cystine/glutamate transporter gene by amino acid deprivation. Biochem Biophysical Res Communicati. 2004;325:109–116. doi: 10.1016/j.bbrc.2004.10.009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbrc.2004.10.009</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gu Y, Albuquerque CP, Braas D, Zhang W, Villa GR, Bi J, Ikegami S, Masui K, Gini B, Yang H, et al.  mTORC2 regulates amino acid metabolism in cancer by phosphorylation of the cystine-glutamate antiporter xCT. Mol Cell. 2017;67:128–138 e127. doi: 10.1016/j.molcel.2017.05.030.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.molcel.2017.05.030</ArticleId>
            <ArticleId IdType="pmc">PMC5521991</ArticleId>
            <ArticleId IdType="pubmed">28648777</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hanawa N, Shinohara M, Saberi B, Gaarde WA, Han D, Kaplowitz N. Role of JNK translocation to mitochondria leading to inhibition of mitochondria bioenergetics in acetaminophen-induced liver injury. J Biol Chem. 2008;283:13565–13577. doi: 10.1074/jbc.M708916200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M708916200</ArticleId>
            <ArticleId IdType="pmc">PMC2376214</ArticleId>
            <ArticleId IdType="pubmed">18337250</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Win S, Than TA, Le BH, Garcia-Ruiz C, Fernandez-Checa JC, Kaplowitz N. Sab (Sh3bp5) dependence of JNK mediated inhibition of mitochondrial respiration in palmitic acid induced hepatocyte lipotoxicity. J Hepatol. 2015;62:1367–1374. doi: 10.1016/j.jhep.2015.01.032.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jhep.2015.01.032</ArticleId>
            <ArticleId IdType="pmc">PMC4439305</ArticleId>
            <ArticleId IdType="pubmed">25666017</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee YH, Govinda B, Kim JC, Kim TI, Lee NH, Lee JC, Yi HK, Jhee EC. Oxidative stress resistance through blocking Hsp60 translocation followed by SAPK/JNK inhibition in aged human diploid fibroblasts. Cell Biochem Funct. 2009;27:35–39. doi: 10.1002/cbf.1531.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/cbf.1531</ArticleId>
            <ArticleId IdType="pubmed">19107874</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li XY, Leung PS. Erastin-induced ferroptosis is a regulator for the growth and function of human pancreatic islet-like cell clusters. Cell Regen. 2020;9:16. doi: 10.1186/s13619-020-00055-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13619-020-00055-3</ArticleId>
            <ArticleId IdType="pmc">PMC7475162</ArticleId>
            <ArticleId IdType="pubmed">32893325</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang Y, Lin Z, Han Z, Wu Z, Hua J, Zhong R, Zhao R, Ran H, Qu K, Huang H, et al.  miR-539 activates the SAPK/JNK signaling pathway to promote ferropotosis in colorectal cancer by directly targeting TIPE. Cell Death Dis. 2021;7:272. doi: 10.1038/s41420-021-00659-x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41420-021-00659-x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kamphorst JJ, Nofal M, Commisso C, Hackett SR, Lu W, Grabocka E, Vander Heiden MG, Miller G, Drebin JA, Bar-Sagi D, et al.  Human pancreatic cancer tumors are nutrient poor and tumor cells actively scavenge extracellular protein. Cancer Res. 2015;75:544–553. doi: 10.1158/0008-5472.CAN-14-2211.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/0008-5472.CAN-14-2211</ArticleId>
            <ArticleId IdType="pmc">PMC4316379</ArticleId>
            <ArticleId IdType="pubmed">25644265</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tong H, Yin H, Hossain MA, Wang Y, Wu F, Dong X, Gao S, Zhan K, He W. Starvation-induced autophagy promotes the invasion and migration of human bladder cancer cells via TGF-β1/Smad3-mediated epithelial-mesenchymal transition activation. J Cell Biochem. 2019;120:5118–5127. doi: 10.1002/jcb.27788.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jcb.27788</ArticleId>
            <ArticleId IdType="pubmed">30320898</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stone TW. Dependence and guidance receptors-DCC and Neogenin-in partial EMT and the actions of serine proteases. Front Oncol. 2020;10:94. doi: 10.3389/fonc.2020.00094.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fonc.2020.00094</ArticleId>
            <ArticleId IdType="pmc">PMC7010924</ArticleId>
            <ArticleId IdType="pubmed">32117748</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim WK, Kwon Y, Jang M, Park M, Kim J, Cho S, Jang DG, Lee WB, Jung SH, Choi HJ, et al.  β-catenin activation down-regulates cell-cell junction-related genes and induces epithelial-to-mesenchymal transition in colorectal cancers. Sci Rep. 2019;9:18440. doi: 10.1038/s41598-019-54890-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41598-019-54890-9</ArticleId>
            <ArticleId IdType="pmc">PMC6895046</ArticleId>
            <ArticleId IdType="pubmed">31804558</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Coppock JD, Vermeer PD, Vermeer DW, Lee KM, Miskimins WK, Spanos WC, Lee JH. mTOR inhibition as an adjuvant therapy in a metastatic model of HPV+ HNSCC. Oncotarget. 2016;7:24228–24241. doi: 10.18632/oncotarget.8286.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.18632/oncotarget.8286</ArticleId>
            <ArticleId IdType="pmc">PMC5029697</ArticleId>
            <ArticleId IdType="pubmed">27015118</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chan DLH, Segelov E, Wong RS, Smith A, Herbertson RA, Li BT, Tebbutt N, Price T, Pavlakis N. Epidermal growth factor receptor (EGFR) inhibitors for metastatic colorectal cancer. Cochrane Database Syst Rev. 2017;6:CD007047.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6481896</ArticleId>
            <ArticleId IdType="pubmed">28654140</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Demkova L, Kucerova L. Role of the HGF/c-MET tyrosine kinase inhibitors in metastasic melanoma. Mol Cancer. 2018;17:26. doi: 10.1186/s12943-018-0795-z.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12943-018-0795-z</ArticleId>
            <ArticleId IdType="pmc">PMC5817811</ArticleId>
            <ArticleId IdType="pubmed">29455657</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yu S, Chen Z, Zeng X, Chen X, Gu Z. Advances in nanomedicine for cancer starvation therapy. Theranostics. 2019;9:8026–8047. doi: 10.7150/thno.38261.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7150/thno.38261</ArticleId>
            <ArticleId IdType="pmc">PMC6857045</ArticleId>
            <ArticleId IdType="pubmed">31754379</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>D'Aronzo M, Vinciguerra M, Mazza T, Panebianco C, Saracino C, Pereira SP, Graziano P, Pazienza V. Fasting cycles potentiate the efficacy of gemcitabine treatment in in vitro and in vivo pancreatic cancer models. Oncotarget. 2015;6:18545–18557. doi: 10.18632/oncotarget.4186.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.18632/oncotarget.4186</ArticleId>
            <ArticleId IdType="pmc">PMC4621909</ArticleId>
            <ArticleId IdType="pubmed">26176887</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
